Metabolic Extraction of Nifedipine during Absorption from the Rat Small Intestine

Drug Metabolism and Pharmacokinetics

Volumn 17, Issue 6, 2002, Pages 546-553

  Iwao, Takahiro ^a   Inoue, Katsuhisa ^a   Hayashi, Yayoi ^a   Yuasa, Hiroaki ^a   Watanabe, Jun ^b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

absorption; CYP3A; metabolism; nifedipine; rat; small intestine

Indexed keywords

EID: 4844220358     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.17.546     Document Type: Article

References (36)

1. Lin, J. H., Chiba, M. and Baillie, T. A.: Is the role of the small intestine in řst-pass metabolism overemphasized? Pharmacol. Revs., 51: 135-157 (1999).
2. Dresser, G. K., Spence, D. and Bailey, D. G.: Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin. Pharmacokinet., 38: 41-57 (2000).
3. Doherty, M. M. and Charman, W. N.: The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism? Clin. Pharmacokinet., 41: 235-253 (2002).
4. Bailey, D. G., Spence, J. D., Munoz, C. and Arnold, J. M. O.: Interaction of citrus juices with felodipine and nifedipine. Lancet, 337: 268-269 (1991).
5. Bailey, D. G., Arnold, J. M. O. and Spence, J. D.: Grapefruit juice and drugs: how signîcant is the interaction?. Clin. Pharmacokinet., 26: 91-98 (1994).
6. Rashid, T. J., Martin, U., Clarke, H., Waller, D. G., Renwick, A. G. and George, C. F.: Factors aŝecting the absolute bioavailability of nifedipine. Br. J. Clin. Pharmacol., 40: 51-58 (1995).
7. Krishna, R. D. and Klotz, U.: Extrahepatic metabolism of drugs in humans. Clin. Pharmacokinet., 26: 144-160 (1994).
8. Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D. and Thummel, K. E.: Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J. Pharmacol. Exp. Ther., 283: 1552-1562 (1997).
9. Zhang, Q. Y., Dunber, D., Ostrowska, A., Zeisloft, S., Yang, J. and Kaminsky, L. S.: Characterization of human small intestinal cytochromes P-450. Drug Metab. Dispos., 27: 804-809 (1999).
10. Gibbs, M. A., Thummel, K. E., Shen, D. D. and Kunze, K. L.: Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression. Drug Metab. Dispos., 27: 180-187 (1999).
11. Obach, R. S., Zhang, Q. Y., Dunber, D. and Kaminsky, L. S.: Metabolic characterization of the major human small intestinal cytochromes P-450s. Drug Metab. Dispos., 29: 347-352 (2001).
12. Kleinbloesem, C. H., van Brummelen, P., van de Linde, J. A., Voogd, P. J. and Breimer, D. D.: Nifedipine: kinetics and dynamics in healthy subjects. Clin. Pharmacol. Ther., 35: 742-749 (1984).
13. Kelly, J. G. and O‚Malley, K.: Clinical pharmacokinetics of calcium antagonists: an update. Clin. Pharmacokinet., 22: 416-433 (1992).
14. Kondo, S. and Sugimoto, I.: Moment analysis of intravenous, intraduodenal, buccal, rectal and percutaneous nifedipine in rats. J. Pharmacobio-Dyn., 10: 462- 469 (1987).
15. Grundy, J. S., Eliot, L. A. and Foster, R. T.: Extrahepatiĉrst-pass metabolism of nifedipine in the rat. Biopharm. Drug Dispos., 18: 509-522 (1997).
16. Grundy, J. S., Eliot, L. A., Kulmatycki, K. M. and Foster, R. T.: Grapefruit juice and orange juice eŝect on the bioavailability of nifedipine in the rat. Biopharm. Drug Dispos., 19: 175-183 (1998).
17. Mohri, K., Uesawa, Y. and Sagawa, K.: Eŝects of long-term grapefruit juice ingestion on nifedipine pharmacokinetics: induction of rat hepatic P-450 by grapefruit juice. Drug Metab. Dispos., 28: 482-486 (2000).
18. Mohri, K. and Uesawa, Y.: Eŝects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharm. Res., 18: 177-182 (2001).
19. Mihara, K., Matsumura, M., Yoshioka, E., Hanada, K., Nakasa, H., Ohmori, S., Kitada, M. and Ogata, H.: Intestinal řst-pass metabolism of eperisone in the rat. Pharm. Res., 18: 1131-1137 (2001).
20. Yuasa, H., Miyamoto, Y., Iga, T. and Hanano, M.: Determination of kinetic parameters of a carrier-mediated transport in the perfused intestine by two-dimensional laminar flow model: eŝect of the unstirred water layer. Biochim. Biophys. Acta, 856: 219-230 (1986).
21. Horvath, V., Andrea, H. P., Niegreisz, Z., Kocsi, E., Horvai, G., Godorhazy, L., Tolokan, A., Klebovich, I. and Katalin, B. N.: Sensitive high-performance liquid chromatographic determination of nifedipine in dog plasma using an automated sample preparation system with laboratory robot. J. Chromatogr. B., 686: 211-219 (1996).
22. Yuasa, H., Iga, T., Hanano, M. and Watanabe, J.: Comparative assessment of the resistance of the unstirred water layer to solute transport between two diŝerent intestinal perfusion systems. Biochim. Biophys. Acta, 938: 189-198 (1988).
23. Yuasa, H., Matsuda, K. and Watanabe, J.: Influence of anesthetic regimens on intestinal absorption in rats. Pharm. Res., 10: 884-888 (1993).
24. Yuasa, H., Matsuda, K. and Watanabe, J.: Influence of anesthetic regimens on the intestinal absorption of 5-fluorouracil in rats. Biol. Pharm. Bull., 18: 747-752 (1995).
25. Ballard, B. E. and Nelson, E.: Physicochemical properties of drugs that control absorption rate after subcutaneous implantation. J. Pharmacol. Exp. Ther., 135: 120-127 (1962).
26. Yuasa, H., Matsuda, K., Gu, J., Suzuki, E., Yokouchi, I. and Watanabe, J.: Dose-dependent gastrointestinal absorption of 5-fluorouracil in rats in vivo. Biol. Pharm. Bull., 19: 1494-1498 (1996).
27. Amidon, G. L., Sinko, P. J. and Fleisher, D.: Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res., 5: 651-654 (1988).
28. Wachar, V. J., Wu, C.-Y. and Benet, L. Z.: Overlapping substrate specîcities and tissue distribution of cytochrome P450 and P-glycoprotein: implications and drug delivery and activity in cancer chemotherapy. Mol. Carcinog., 13: 129-134 (1995).
29. Kim, R. B., Wandel, C., Leake, B., Cvetkovic, M., Fromm, M. F., Dempsey, P. J., Roden, M. M., Belas, F., Chaudhary, A. K., Roden, D. M., Wood, A. J. J. and Wilkinson, G. R.: Interrelationship between substrates and inhibitors of human CYP3A and Pglycoprotein. Pharm. Res., 16: 408-414 (1999).
30. Newton, D. J., Wang, R. W. and Lu, A. Y. H.: Cytochrome P450 inhibitors: evaluation of specîcities in the in vitro metabolism therapeutic agents by human liver microsomes. Drug Metab. Dispos., 23: 154-158 (1995).
31. Imaoka, S., Yamada, T., Hiroi, T., Hayashi, K., Sakai, T., Yabusaki, Y. and Funae, Y.: Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Biochem. Pharmacol., 51: 1041-1050 (1996).
32. Ishigaki, M., Kawabata, K., Takasaki, W., Ikeda, T., Komai, T., Ito, K. and Sugiyama, Y.: Drug interaction between simvastatin and itraconazole in male and female rats. Drug Metab. Dispos., 29: 1068-1072 (2001).
33. Warrington, J. S., Moltke, L. L. V., Shader, R. I. and Greenblatt, D. J.: In vitro biotransformation of sildenâl (Viagra) in the male rat: the role of CYP2C11. Drug Metab. Dispos., 30: 655-657 (2002).
34. Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P., Wolŝ, T. and Waxman, D. J.: Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem 261: 5051-5060, (1986).
35. Zhang, Q. Y., Wikoŝ, J., Dunber, D., Ostrowska, A.and Kaminsky, L. S.: Characterization of rat small intestinal cytochrome P-450 composition and inducibility. Drug Metab. Dispos., 24: 322-328 (1996).
36. Gushchin, G. V., Gushchin, M. I., Gerber, N. and Boyd, R. T.: A novel cytochrome P450 3A isoenzyme in rat intestinal microsomes. Biochem. Biophys. Res. Commun., 255: 394-398 (1999).